Lv5
1342 积分 2020-09-22 加入
Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRASG12C, in Healthy Chinese Subjects
12天前
已完结
High-dose Furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A prospective real-world study
21天前
已完结
Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
21天前
已完结
Toward personalized treatment approaches for non-small-cell lung cancer
21天前
已完结
Safety and efficacy of anlotinib hydrochloride capsules in advanced non-small-cell lung cancer: a multicenter, real-world study
22天前
已完结
A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancer
22天前
已完结
Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib
22天前
已完结
Anlotinib succeeded in rescue therapy for hyperprogression induced by immune checkpoint inhibitors: a case report
22天前
已完结
Simultaneous Quantitation of Anlotinib and Osimertinib by Isotope-Labeled UHPLC–MS/MS in Human Plasma: Application in NSCLC Patients
22天前
已完结
Multi‐target angiogenesis inhibitor combined with PD‐1 inhibitors may benefit advanced non‐small cell lung cancer patients in late line after failure of EGFR‐TKI therapy
22天前
已完结
皖公网安备34019202002308
